With the Migraine Research Foundation reporting that migraines affect 38 million adults and children in the U.S. (more than diabetes and asthma put together), it's not surprising that Drs. Ken Haycock & Tim Vierheller sees a lot of headache sufferers in our Massillon, OH office. While some folks try to relieve migraine pain with drugs, chiropractic care is a fantastic, all-natural alternative that often produces positive results.
For example, one study published in the Journal of Manipulative and Physiological Therapeutics involved 127 patients ranging in age from 10 to 70-years-old who suffered with regular (at least monthly) migraines. Each subject received up to 16 chiropractic sessions. The subjects noted that their headache frequency, duration, and disability two months before the study began, during the duration of the sessions (which was two months), and two months post-treatment.
What the investigators discovered is that chiropractic reduced the frequency, duration, and disability of the migraine headaches when compared with the control patients who didn't receive chiropractic. In addition, this allowed them to take less medication for the pain, offering them an all-natural solution for a chronic condition.
Another article found that a combination of chiropractic and neck massage reduced migraine pain almost 68%.
If you have migraine pain and are looking for help, call Drs. Ken Haycock & Tim Vierheller today and request an appointment in our Massillon, OH chiropractic office. We'll do what we can to help you become pain-free!
Migraine Fact Sheet. Migraine Research Foundation. Retrieved from http://www.migraineresearchfoundation.org/fact-sheet.html on November 2, 2015
Noudeh Y et al. (2012). Reduction of current migraine headache pain following neck massage and spinal manipulation. International Journal of Therapeutic Massage & Bodywork;5(1):5-13
Tuchin P et al. (2000, February). A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. Journal of Manipulative and Physiological Therapeutics;23(2):91-5